Wheat Bran | whatsinit

About

What it is and where it shows up.

Wheat bran is the hard outer layer of the wheat kernel (Triticum aestivum), separated during milling; it is rich in dietary fibre (particularly arabinoxylan and cellulose), B vitamins, and minerals. It is used in food products such as breakfast cereals, breads, and multigrain flours to increase dietary fibre content, promote intestinal transit, and improve faecal bulk.

Safety summary

The regulatory and scientific consensus.

Wheat bran is broadly safe for the general population and is not classified as a food additive requiring pre-market approval in any major jurisdiction. In vitro genotoxicity assays (Ames test and chromosome aberration assay) on wheat bran extract showed no mutagenic or clastogenic activity, and a 90-day rat-feeding study established a NOAEL of 4.4 g/kg bw/day. It contains gluten and is strictly contraindicated for individuals with celiac disease or wheat allergy; high phytate content may also reduce bioavailability of iron, zinc, and calcium when consumed in very large quantities.

Regulatory landscape

What food-safety regulators have decided.

Jurisdiction	Status	Note
EFSA (European Food Safety Authority) (European Union)	Approved	Wheat bran is not a regulated food additive and carries no E number in the EU. EFSA substantiated health claims for wheat bran fibre related to reduction of intestinal transit time and increase in faecal bulk (EFSA Journal 2010, Question No. EFSA-Q-2008-1626). No ADI established.source
FSSAI (Food Safety and Standards Authority of India) (India)	Approved	FSSAI published draft amendment regulations in February 2019 to formally establish product standards for wheat bran under the Food Safety and Standards (Food Products Standards and Food Additives) Amendment Regulations, 2019. Separate mycotoxin limits (DON and OTA) in wheat bran are also under review by FSSAI.source
FDA (Food and Drug Administration) (United States)	Approved	Wheat bran is a conventional whole-food ingredient with a long history of safe use in food; it is not classified as a food additive and is not subject to pre-market FDA review. It is used in cereal and bakery products (21 CFR Part 137). No ADI has been established.source

Who should approach with care

Whose guidance would steer them away.

Gluten Intolerance — Wheat bran contains gluten proteins and is strictly contraindicated for individuals with celiac disease or non-celiac gluten sensitivity, as it can trigger immune-mediated intestinal damage and malabsorption.

Infants — High insoluble dietary fibre from wheat bran is not appropriate for infants, as it can interfere with energy and micronutrient absorption; Codex Alimentarius and FSSAI infant food standards do not permit wheat bran in infant formula.

Kidney Disease — Wheat bran is high in phosphorus and phytate; patients with chronic kidney disease may need to limit intake to prevent exacerbation of hyperphosphatemia.

Ibs — High insoluble fibre intake from wheat bran may worsen bloating, gas, and diarrhoea in some IBS patients, particularly those with IBS-diarrhoea predominant subtype; tolerance is highly individual.

Ibd — During active flares of Crohn's disease or ulcerative colitis, high-fibre foods including wheat bran may aggravate symptoms; consumption should be guided by a gastroenterologist.

Research citations

The sources behind this verdict.

1FDA. Generally Recognized as Safe (GRAS) — FDA. fda.gov
2FSSAI. Draft Food Safety and Standards (Food Products Standards and Food Additives) Amendment Regulations, 2019 — Standards of Wheat Bran and Non-Fermented Soybean Products, 2019. archive.fssai.gov.in
3EFSA. Scientific Opinion on the risks for public health related to the presence of zearalenone in food, 2011. efsa.europa.eu
4EFSA. Scientific Opinion on the substantiation of health claims related to wheat bran fibre and increase in faecal bulk, reduction of intestinal transit time, and weight management, 2010. efsa.europa.eu
5PubMed. Safety assessment of a wheat bran extract containing arabinoxylan-oligosaccharides: mutagenicity, clastogenicity, and 90-day rat-feeding studies, 2010. pubmed.ncbi.nlm.nih.gov

Independently researched5 citations